Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion and 'Positively Smoke Free' for Smoking Cessation in HIV+ Patients
NCT03342027Phase 3Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Aug 2020
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupropion in tobacco dependence, sponsored by University of Maryland, Baltimore. Started Aug 2020; status: completed.
02
Drugs
bupropion
03
Conditions
tobacco dependence
Beyond the preview
Go deeper on NCT03342027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03342027.